🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE:300573)
China flag China · Delayed Price · Currency is CNY
32.95
-1.74 (-5.02%)
Nov 20, 2026, 3:04 PM CST

SHE:300573 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
802.06695.86338.06240.04211.68194.7
Depreciation & Amortization
110.27110.27102.588.8174.3767.28
Other Amortization
5.015.0144.535.656.21
Loss (Gain) From Sale of Assets
-0.05-0.050.980.04-0.42-5.16
Asset Writedown & Restructuring Costs
3.73.714.05-00
Loss (Gain) From Sale of Investments
------3.14
Provision & Write-off of Bad Debts
1.081.083.323.030.93-0.19
Other Operating Activities
50.9919.1710.5410.235.5324.49
Change in Accounts Receivable
-174.85-174.85-144.42-104.38-37.51-33.43
Change in Inventory
-47.6-47.6-20.99-22.05-34.35-27.8
Change in Accounts Payable
129.83129.8395.5473.1723.5173.27
Change in Other Net Operating Assets
6.66.611.5523.4242.4713.31
Operating Cash Flow
891.4753.39416.98317.57286.26306.96
Operating Cash Flow Growth
40.19%80.68%31.30%10.94%-6.74%151.28%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-277.5-270.53-198.71-261.96-299.23-95.06
Sale of Property, Plant & Equipment
0.20.050.330.020.0819.03
Divestitures
-0.64----1.26
Investment in Securities
---10---130.24
Other Investing Activities
1.560.74-7.28--3
Investing Cash Flow
-276.38-269.74-215.67-261.94-299.15-202.01

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
-1813107020100
Total Debt Issued
1391813107020100
Short-Term Debt Repaid
--311-180--120-80
Long-Term Debt Repaid
--11.66-8.93-7.67-6.17-8.7
Lease Payments
-11.66-11.66-8.93-7.67-6.17-8.7
Total Debt Repaid
-181.66-322.66-188.93-7.67-126.17-88.7
Net Debt Issued (Repaid)
-42.66-141.66121.0762.33-106.1711.3
Issuance of Common Stock
19.2219.2222.1725.327.56580.18
Repurchase of Common Stock
----16.81--0.27
Common Dividends Paid
-354-351.08-466.57-178.49-80.84-47.13
Other Financing Activities
-80.9515.134.5523.51.02-5.95
Financing Cash Flow
-458.4-458.39-318.79-84.17-158.42538.12

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
1.68-1.67-0.110.2-0.09-0.13
Net Cash Flow
158.3123.59-117.58-28.34-171.4642.94

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
613.91482.86218.2755.61-12.96211.9
Free Cash Flow Growth
49.93%121.22%292.54%--1412.86%
Free Cash Flow Margin
21.87%19.53%11.23%3.79%-1.04%20.61%
Free Cash Flow Per Share
1.721.350.610.16-0.040.65
Levered Free Cash Flow
604.68446.06206.99-22.52-104.31127.3
Unlevered Free Cash Flow
605.78448.83210.56-21.62-103.72131.04
Free Cash Flow After Leases
602.24471.2209.3547.93-19.13203.2

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
378.31308.88215.15109.68134.28103.23
Change in Working Capital
-81.65-81.65-56.47-29.11-11.4922.76